Evidence map›Paper›PMID 32653032›Full record

ArticleJournal of experimental & clinical cancer research : CR2020

Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.

Xiaoqi Chen, Jing Jiang, Yunxia Zhao, Xinting Wang, Chuanlei Zhang, Lv Zhuan, Danyang Zhang, Yuling Zheng

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Circular RNAs and Cancers.Advances in experimental medicine and biology · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Circ_0024108 promotes the progression of esophageal cancer cells.General thoracic and cardiovascular surgery · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xiaoqi ChenDepartment of Gastroenterology, The First Affiliated Hospital of Henan University of Chinese Medicine, No. 19 Renmin Road, Jinshui District, Zhengzhou, 450000, China. akkwedo@126.com.
Jing JiangSchool of Mechanical and Power Engineering, Zhengzhou University, Zhengzhou, 450000, China. jiangjing@zzu.edu.cn.
Yunxia ZhaoHenan University of Chinese Medicine, Zhengzhou, 450000, China.
Xinting WangDepartment of Gastroenterology, The First Affiliated Hospital of Henan University of Chinese Medicine, No. 19 Renmin Road, Jinshui District, Zhengzhou, 450000, China.
Chuanlei ZhangDepartment of Gastroenterology, The First Affiliated Hospital of Henan University of Chinese Medicine, No. 19 Renmin Road, Jinshui District, Zhengzhou, 450000, China.
Lv ZhuanDepartment of Medical Administration, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, China.
Danyang ZhangDepartment of Pharmacy, Zhengzhou Hospital of Traditional Chinese Medicine, Zhengzhou, 450000, China.
Yuling ZhengGuoyitang, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, China.
First Affiliated Hospital of Henan University · CNZhengzhou City Hospital · CNZhengzhou University · CN

Funding

National Natural Science Foundation Youth Fund of China 81804063Postdoctoral Science Foundation of Jiangsu Province 2019M662500Special Project of Traditional Chinese Medicine Research in Henan Province 2018ZY2032
6 · The paper itself

Abstract

backgroundEsophageal squamous cell carcinoma (ESCC) is one of the most prevalent gastrointestinal malignancies with high mortality. Circular RNAs (CircRNAs) have become a research hotspot in recent years for their vital roles in cancer development and progression. This study aims to clarify the roles of circNTRK2 and its underlying molecular mechanisms in ESCC.

methodsThe levels of circNTRK2, miR-140-3p, and nuclear receptor-interacting protein 1 (NRIP1) mRNA were examined by qRT-PCR. The cell proliferation ability was detected via CCK-8, EdU and colony formation assays. The invasion capacity was tested by using transwell assay. The apoptotic rate was evaluated through flow cytometry. The protein levels of cleaved PARP, cleaved caspase-3, E-cadherin, vimentin, and NRIP1 were measured by western blot assay. The validation of circular structure was performed by Sanger sequencing, divergent primer PCR, and RNase R treatments. The ceRNA regulatory mechanism of circNTRK2 was observed via dual-luciferase reporter, RIP and RNA pull-down assays. The mice xenograft models were constructed to confirm the oncogenicity of circNTRK2 in ESCC in vivo.

resultsCircNTRK2 was highly expressed in ESCC tissues and cells. High expression of circNTRK2 was correlated with advanced TNM stage, lymph node metastasis and short survival. Knockdown of circNTRK2 inhibited ESCC cell proliferation, invasion and epithelial-mesenchymal transition (EMT), and accelerated apoptosis in vitro. Mechanistic assays disclosed that circNTRK2 could act as a sponge for miR-140-3p to abate its suppression on target NRIP1 expression. Moreover, miR-140-3p-induced inhibitory effects on ESCC cell malignant phenotypes were attenuated by the overexpression of circNTRK2. In addition, depletion of NRIP1 impeded cell proliferation, invasion and EMT, while enhanced apoptosis. Furthermore, silencing of circNTRK2 suppressed cell proliferation and invasion through regulating NRIP1 expression. Also, knockdown of circNTRK2 slowed ESCC tumor growth in vivo.

conclusionCircNTRK2 promoted ESCC progression by regulating miR-140-3p/NRIP1 pathway. Our findings contribute to a better understanding of circRNAs as miRNA sponges and highlight a promising therapy target in ESCC.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsApoptosisBiomarkers, TumorCell MovementCell ProliferationEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaFemaleHumansMaleMembrane GlycoproteinsMiceMice, Inbred BALB CMice, NudeMicroRNAsBiomarkers, TumorMembrane GlycoproteinsMicroRNAsMirn140 microRNA, humanNRIP1 protein, humanNuclear Receptor Interacting Protein 1Receptor, trkBRNA, Circulartropomyosin-related kinase-B, humancircNTRK2Esophageal squamous cell carcinomamiR-140-3pNuclear receptor-interacting protein 1

Identifiers

PMID32653032
PMCPMC7353745
OpenAlexW3041097893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.